Fmoc-Chg-OH

Catalog No.: 
ACPBOD064
CAS No.: 
161321-36-4
Molecular Formula: 
C23H25NO4
Molecular Weight: 
379.46
Fmoc-Chg-OH structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g97%$67.00In stockInquiry
500g97%$334.00In stockInquiry
1000g97%$534.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameFmoc-Chg-OH
IUPAC Name(S)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylacetic acid
MDL No.MFCD00190878
Molecular FormulaC23H25NO4
Molecular Weight379.46
SMILESO=C(O)[C@@H](NC(OCC1C2=C(C3=C1C=CC=C3)C=CC=C2)=O)C4CCCCC4
InChI KeyBWQQGHPODCJZDB-NRFANRHFSA-N
SynonymMFCD00190878 | (2S)-2-cyclohexyl-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)acetic acid | (S)-2-cyclohexyl-[(9H-fluoren-9-ylmethoxycarbonylamino)]-acetic acid | Fmoc-cyclohexyl-Gly-OH | (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-cyclohexylaceti
CAS No.161321-36-4
PubChem CID6976353

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACPBOD064 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACLOWQ492 route compound structure diagram
    ACLOWQ492191611-20-8In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPBOD064 route product structure diagram
    ACPBOD064161321-36-4In Stock
Inquiry

2. ACPBOD064 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPBOD064 route product structure diagram
    ACPBOD064161321-36-4In Stock
Inquiry

3. ACPBOD064 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPBOD064 route product structure diagram
    ACPBOD064161321-36-4In Stock
Inquiry

Comments (0)